Vogs M 0.3 Tablet

Drug | Tablet

Type 2 diabetes mellitus (to control post-meal and overall blood glucose) when diet and exercise alone are insufficient; used alone or with other antidiabetic medicines as prescribed.

Voglibose inhibits intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and reducing post-meal blood sugar spikes. Metformin decreases glucose production in the liver and improves insulin sensitivity, lowering fasting and overall blood glucose.

Tablet for oral use. Usually taken with meals; voglibose is typically taken just before the first bite of each main meal. Swallow whole with water; follow the dose and schedule advised by your doctor and monitor blood glucose regularly.

Flatulence, abdominal pain, diarrhoea, nausea, vomiting, loss of appetite, metallic taste, headache, dizziness, hypoglycaemia (when used with insulin/sulfonylureas), vitamin B12 deficiency (long-term), rash

Use with caution in kidney or liver impairment; metformin is generally avoided in severe renal dysfunction due to risk of lactic acidosis. Temporarily stop metformin before/after iodinated contrast studies and during major surgery as advised. Seek urgent care for symptoms of lactic acidosis (deep/rapid breathing, severe weakness, muscle pain, abdominal discomfort). Voglibose may cause significant gas/diarrhoea; avoid in intestinal obstruction or severe inflammatory bowel disease. Monitor renal function, HbA1c, and vitamin B12 with long-term use.